STAT3 stimulates adipogenic stem cell proliferation and cooperates with HMGA2 during the early stage of differentiation to promote adipogenesis

https://doi.org/10.1016/j.bbrc.2016.12.042Get rights and content

Highlights

  • We discovered an activation of STAT3 during the early differentiation stage of mouse 3T3-L1 preadipocytes.

  • Stat3 knockdown using siRNA blocked cell cycle progression of both preadipoctes and early differentiating cells.

  • Accumulation of lipid droplets was inhibited by Stat3 knockdown.

  • STAT3 protein co-localized with HMGA2, which was reported to promote adipogenesis in a previous study.

Abstract

Signal transducer and activator of transcription 3 (STAT3) is abundantly expressed in the adipose tissue of obese mice and humans, but the role of STAT3 in adipogenesis is still not fully understood. In the present study, we discovered an activation of STAT3 during the early differentiation stage of mouse 3T3-L1 preadipocytes. Stat3 knockdown using siRNA blocked cell cycle progression of both preadipoctes and early differentiating cells. Moreover, accumulation of lipid droplets was inhibited by Stat3 knockdown. Importantly, in the nucleus of early differentiating cells, we demonstrated that STAT3 protein co-localized with high-mobility-group protein AT-hook 2 (HMGA2), which was reported to promote adipogenesis in a previous study. Taken together, our data indicate that STAT3 and HMGA2 cooperatively promote adipogenesis which highlight a more detail understanding of STAT3 related transcription factor network during adipogenesis.

Introduction

Obesity is a chronic, low-grade inflammatory disease that is associated with various diseases, including type 2 diabetes, hypertension, cardiovascular disease, nonalcoholic fatty liver disease and cancers [1], and is becoming a worldwide public health threat. Obesity is primarily caused by abnormal lipolysis, lipogenesis, and adipocyte differentiation and proliferation [3]. Inhibiting adipocyte differentiation and proliferation can be an effective strategy for preventing obesity [4]. The mouse 3T3-L1 cell line resembles pre-adipocytes morphologically and structurally, and is widely used as an in vitro adipogenic differentiation model [5]. Adipogenic differentiation of 3T3-L1 cells consists of three distinct stages: contact inhibition, clonal expansion, and terminal adipogenic differentiation [6].

In mammals, the signal transducer and activator of transcription (STAT) family has seven members: STAT1-4, STAT5a/b, and STAT6. STAT3 is an important transcription factor involved in many biological events, such as tumorigenesis, angiogenesis [7], [8], epithelial-to-mesenchymal transition (EMT) and apoptosis [9]. Constitutive activation of STAT3 is frequently observed in colon cancer-initiating cells and is associated with invasion, survival, and growth of colorectal cancer cells in vivo and in vitro [10], [11], [12]. Inhibition of STAT3 induces apoptosis and suppresses cell proliferation in various kinds of cancers [13], [14]. In 1996, Stephens et al. first observed that the STAT3 was abundantly expressed in proliferating pre-adipocytes [15]. IL-6-type cytokines (IL-6, IL-10, IL-11, LIF, CT-1, OSM, and CNTF), predominantly IL-6 itself, phosphorylate STAT3 via binding with GP130 and activating JAKs [16]. Zhang et al. [17] confirmed that the JAK2/STAT3 pathway was involved in the early stage of differentiation through regulating C/EBPβ transcription. It is also reported that activation of STAT3 regulated adipocyte differentiation through signaling that occurred upstream of PPARγ [18]. High-mobility-group protein AT-hook 2 (HMGA2), a sequence-specific DNA-binding protein, is directly linked to hyperplasia of white adipose tissue (WAT) and obesity [19], [20]. HMGA2 is barely detectable in mature tissues, while it is highly expressed in various stem cells, suggesting that HMGA2 functions at the early developmental stage [21], [22]. Moreover, we have reported that pulsatile expression of HMGA2 at the early stage of adipogenesis drives C/EBPβ-mediated induction of PPARγ and promotes adipocyte differentiation [23]. However, the relationship between HMGA2 and STAT3 is not known.

In this study, we provide evidence that STAT3 is activated at the early stage of adipocyte differentiation and promotes adipogenesis by stimulating 3T3-L1 stem cell proliferation. Our study suggests that STAT3 plays an essential role in the induction of adipogenesis.

Section snippets

Cell culture and treatment

3T3-L1 adipogenic stem cells were cultured in high-glucose (4.5 g/L) DMEM containing 10% fetal bovine serum (FBS) and penicillin/streptomycin (both at 100 U/ml) at 37 °C with 5% CO2. Cells were maintained for 2 days post-confluence and then treated with 1.0 μM dexamethasone (Sigmae-Aldrich), 0.5 mM 3-isobutyl-1- methylxanthine (Sigmae-Aldrich), and 5.0 μg/ml bovine insulin (Sigmae-Aldrich) to initiate differentiation (designated as day 0) for 48 h followed by maintenance in DMEM/10% FBS

STAT3 is activated at the early stage of adipogenesis and up-regulated in fat tissues under HFD condition

As shown in Fig. 1A, Western blots were probed with antibodies specific for total and phosphorylated STAT3. The pho-STAT3 protein level was elevated at 3 h after the initiation of differentiation and continued to increase during the first 24 h of differentiation. Then it declined to a basal level by 48 h and remained at a low level until 168 h. The total STAT3 protein level also gradually increased and the highest expression was at 72 h after the initiation of differentiation. The mRNA level of

Discussion

Previous studies have demonstrated that STAT3 is involved in obesity and cancer [26], [27]. High STAT3 expression promotes EMT and colonic tumor progression [26]. In the present work, we observed a high-level activation of STAT3 during the very early stage of adipogenesis (Fig. 1A), which is in good accordance with a previous study showing that STAT3 was tyrosine phosphorylated and bound to DNA during preadipocyte proliferation and differentiation [28]. Activation of STAT3 has been shown to

Competing financial interests

The authors have no competing financial interests.

Acknowledgements

This work was supported by Ningbo Science and Technology Innovation Team Program (2014B82002 to SB), the National Natural Science Foundation of China (81370165 to SB, 81501421 to FW, 31301068 to YX), Fang Runhua Fund of Hong Kong, and K. C. Wong Magna Fund in Ningbo University.

References (32)

  • M.C. Mitterberger et al.

    Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes

    J. Gerontol. A Biol. Sci. Med. Sci.

    (2013)
  • L.H. Wei et al.

    Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

    Oncogene

    (2003)
  • J. Sun et al.

    Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors

    Oncogene

    (2005)
  • Y. Yang et al.

    Regulation of transforming growth factor-beta 1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3

    Cancer Res.

    (2006)
  • T. Ashizawa et al.

    Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma

    Int. J. Oncol.

    (2013)
  • L. Lin et al.

    STAT3 is necessary for proliferation and survival in colon cancer-initiating cells

    Cancer Res.

    (2011)
  • Cited by (44)

    • Induction of microRNA hsa-let-7d-5p, and repression of HMGA2, contribute protection against lipid accumulation in macrophage ‘foam’ cells

      2021, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
      Citation Excerpt :

      The impact of let-7d inhibition on expression of HMGA2 (Fig. 2C) in sterol-loaded cells translated into a significant (32%; p < 0.05) increase in the level of HMGA2 protein, relative to β-actin, in THP-1 macrophages treated with Ac-LDL (Fig. 4A). Notably, HMGA2 has been linked with increased adipogenesis [58,59], but no changes in expression of PPARG or CEBPB were detected in THP-1 macrophage ‘foam’ cells after treatment with let-7d inhibitor (data not shown). Gene expression of E2F was also investigated under the same conditions, with no significant change noted in three independent experiments (data not shown).

    • Signal transducer and activator of transcription 3 as a potential therapeutic target for Graves’ orbitopathy

      2021, Molecular and Cellular Endocrinology
      Citation Excerpt :

      Furthermore, adipogenic differentiation of siSTAT3-transfected orbital fibroblasts showed that silencing STAT3 curtailed C/EBPβ expression beginning on day 6, which subsequently inhibited the expression of terminal adipogenesis markers (downstream transcription factors, such as aP2, leptin, and adiponectin) and adipocyte differentiation. These results suggest that STAT3 may be involved in preadipocyte proliferation (an early stage of adipogenesis) in GO orbital adipose tissue, as found using other models of adipogenesis (Burrell et al., 2020; Zhang et al., 2011; Yuan et al., 2017). Oxidative stress can lead to STAT3 phosphorylation and nuclear translocation, and subsequent activation of the STAT3 signalling pathway in lymphocytes and fibroblasts (Carballo et al., 1999; Simon et al., 1998).

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text